Drug Concentration-Time Profile in the Plasma Following the Dissolution-Type Transdermal Delivery.
- 1 January 2003
- journal article
- Published by Taylor & Francis in JOURNAL OF CHEMICAL ENGINEERING OF JAPAN
- Vol. 36 (1) , 45-48
- https://doi.org/10.1252/jcej.36.45
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Development of Transdermal Formulation of Tulobuterol for the Treatment of Bronchial AsthmaYAKUGAKU ZASSHI, 2002
- Prediction of Plasma Concentration of GTS-21 in Hairless Rats Following Monolithic Transdermal Delivery.Biological & Pharmaceutical Bulletin, 2002
- Fentanyl Remaining in a Transdermal System Following Three Days of Continuous UseAnnals of Pharmacotherapy, 1995
- Intermittent Transdermal Nitroglycerin Therapy in Angina PectorisCirculation, 1995
- Pharmacokinetic Characterisation of Transdermal Delivery SystemsClinical Pharmacokinetics, 1994
- Species Differences in Percutaneous Absorption of NicorandilJournal of Pharmaceutical Sciences, 1991
- Pharmacokinetic Considerations in the Use of Newer Transdermal FormulationsClinical Pharmacokinetics, 1988
- Drug Permeation Across the Skin: Effect of Penetrant HydrophilicityJournal of Pharmaceutical Sciences, 1987
- Membrane transport of drug under nonisothermal conditions.JOURNAL OF CHEMICAL ENGINEERING OF JAPAN, 1987